Acadian Asset Management’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $12.3M | Sell |
128,655
-23,182
| -15% | -$2.11M | 0.01% | 530 |
|
|
2026
Q1 | $14.6M | Buy |
151,837
+2,386
| +2% | +$239K | 0.02% | 441 |
|
|
2025
Q4 | $14.5M | Buy |
149,451
+4,173
| +3% | +$358K | 0.02% | 395 |
|
|
2025
Q3 | $10.3M | Sell |
145,278
-8,961
| -6% | -$597K | 0.02% | 476 |
|
|
2025
Q2 | $9.22M | Sell |
154,239
-2,080
| -1% | -$114K | 0.02% | 449 |
|
|
2025
Q1 | $8.2M | Buy |
156,319
+15,329
| +11% | +$861K | 0.02% | 374 |
|
|
2024
Q4 | $7.75M | Buy |
140,990
+3,863
| +3% | +$203K | 0.02% | 411 |
|
|
2024
Q3 | $6.89M | Sell |
137,127
-5,898
| -4% | -$272K | 0.02% | 416 |
|
|
2024
Q2 | $6.28M | Sell |
143,025
-13,630
| -9% | -$580K | 0.02% | 447 |
|
|
2024
Q1 | $6.89M | Sell |
156,655
-19,972
| -11% | -$883K | 0.02% | 388 |
|
|
2023
Q4 | $8.38M | Sell |
176,627
-5,156
| -3% | -$217K | 0.03% | 329 |
|
|
2023
Q3 | $8.06M | Hold |
181,783
| – | – | 0.03% | 328 |
|
|
2023
Q2 | $8.67M | Buy |
181,783
+1,707
| +0.9% | +$77K | 0.04% | 326 |
|
|
2023
Q1 | $7.08M | Buy |
180,076
+14,023
| +8% | +$510K | 0.03% | 372 |
|
|
2022
Q4 | $4.7M | Buy |
166,053
+262
| +0.2% | +$7.5K | 0.02% | 463 |
|
|
2022
Q3 | $4.98M | Hold |
165,791
| – | – | 0.03% | 399 |
|
|
2022
Q2 | $5.63M | Buy |
165,791
+22,253
| +16% | +$798K | 0.03% | 383 |
|
|
2022
Q1 | $6.43M | Buy |
143,538
+86,208
| +150% | +$3.99M | 0.03% | 408 |
|
|
2021
Q4 | $2.65M | Buy |
57,330
+35,766
| +166% | +$1.44M | 0.01% | 595 |
|
|
2021
Q3 | $723K | Buy |
21,564
+20,259
| +1,552% | +$689K | ﹤0.01% | 940 |
|
|
2021
Q2 | $38K | Buy |
+1,305
| New | +$36K | ﹤0.01% | 1841 |
|
|
2020
Q4 | – | Sell |
-6,667
| Closed | -$142K | – | 2272 |
|
|
2020
Q3 | $142K | Sell |
6,667
-30,413
| -82% | -$683K | ﹤0.01% | 1562 |
|
|
2020
Q2 | $860K | Sell |
37,080
-1,077
| -3% | -$23.1K | ﹤0.01% | 1015 |
|
|
2020
Q1 | $815K | Buy |
38,157
+9,510
| +33% | +$226K | ﹤0.01% | 855 |
|
|
2019
Q4 | $671K | Buy |
28,647
+11,502
| +67% | +$269K | ﹤0.01% | 1000 |
|
|
2019
Q3 | $360K | Buy |
17,145
+1,461
| +9% | +$29.8K | ﹤0.01% | 1172 |
|
|
2019
Q2 | $321K | Sell |
15,684
-14,080
| -47% | -$332K | ﹤0.01% | 1121 |
|
|
2019
Q1 | $836K | Buy |
29,764
+2,920
| +11% | +$76.4K | ﹤0.01% | 953 |
|
|
2018
Q4 | $657K | Buy |
26,844
+22,375
| +501% | +$601K | ﹤0.01% | 842 |
|
|
2018
Q3 | $166K | Buy |
4,469
+3,006
| +205% | +$81.1K | ﹤0.01% | 1103 |
|
|
2018
Q2 | $30K | Buy |
+1,463
| New | +$25.9K | ﹤0.01% | 1487 |
|
|
2018
Q1 | – | Sell |
-4,234
| Closed | -$64K | – | 1747 |
|
|
2017
Q4 | $64K | Buy |
4,234
+2,117
| +100% | +$26.9K | ﹤0.01% | 1187 |
|
|
2017
Q3 | $20K | Buy |
+2,117
| New | +$20.1K | ﹤0.01% | 1223 |
|
|
2015
Q4 | – | Sell |
-8,578
| Closed | -$209K | – | 1453 |
|
|
2015
Q3 | $209K | Buy |
+8,578
| New | +$205K | ﹤0.01% | 898 |
|
Other funds holding IRMD
CCM
VCM
Acadian Asset Management's IRMD Position: Q2 2026 in Review
Acadian Asset Management reduced its iRadimed (IRMD) stake by 15% in Q2 2026, selling an estimated $2.11M and leaving 128,655 shares worth $12.3M. The position accounts for 0.01% of the portfolio, ranked #530.
Acadian Asset Management first reported a position in IRMD in Q3 2015 and has held it in 34 quarters since. The position peaked at $14.6M in Q1 2026. 159 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.
- Acadian Asset Management held 128,655 shares of iRadimed worth $12.3M as of Q2 2026.
- Acadian Asset Management sold 23,182 iRadimed shares in Q2 2026, an estimated $2.11M.
- iRadimed made up 0.01% of Acadian Asset Management's portfolio in Q2 2026, its #530 holding.
- Acadian Asset Management first reported a position in iRadimed in Q3 2015 and has held it in 34 quarters since.
- Acadian Asset Management's iRadimed position peaked at $14.6M in Q1 2026.
- 159 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.
Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.